“This is a convenient method for patients to use pills they already have,” she says. Both doses of pills should be taken as soon as possible, ideally within 72 hours (three days) of unprotected sex, ...

Male contraception, a long-standing and confidential research topic, is gaining momentum. Hormonal, nonhormonal, and reversible surgical methods are advancing rapidly, reflecting the growing demand ...

Elina Berglund, the co-founder and co-CEO of Natural Cycles, was user zero for the first-ever FDA-cleared birth control app. Now she’s building for the next phase of her life—and the lives of millions ...

Elizabeth Nethery receives funding from Health Research BC. Amanda Black has received research funding from CIHR. She sits on the Board of Directors of the Society of Obstetricians and Gynaecologists ...

Speed demons know pulling out as a merging strategy, while politicians use it synonymously with dropping out. But in the sexicon—yes, that’s sex lexicon—pulling out refers to an 'effective' birth ...

Two years after the U.S. Food and Drug Administration approved the first over-the-counter birth control pill, new research is looking at who's switching to it and why. In the study, published Monday ...

A new study suggests that the first over-the-counter birth control pill approved in the U.S. is reaching people who previously had little or no access to contraception. Researchers at Oregon Health & ...

A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...

This article is part of TPM Cafe, TPM’s home for opinion and news analysis. It was originally published at The Conversation. On June 24, 2022, the U.S. Supreme Court decision in Dobbs v. Jackson Women ...

Cynthia H. Chuang receives funding from the Agency for Healthcare Research and Quality. Carol S. Weisman does not work for, consult, own shares in or receive funding from any company or organization ...

Often citing concerns about side effects, Gen Z women (born between 1997 and 2012), increasingly are shunning evidence-based family planning and reproductive health counsel, turning instead to advice ...

The United States was a key supplier of contraceptives in many developing countries. The Trump administration has ended that support. By Stephanie Nolen Stephanie Nolen covers global health. The ...